This resubmission of the renewal application requests continued support for a well-established, vibrant and productive Training Program in the Immunobiology of Blood and Vascular Systems (IBVSTP) at Vanderbilt University. IBVSTP is focused on inflammation as the major mechanism of diseases that significantly alter blood and vascular systems in response to diverse microbial, autoimmune, and metabolic insults. This innovative training platform for mentoring and career development of graduate students, including dual degree students, and postdoctoral fellows has proven its effectiveness as attested by a rapidly growing number of fruitful collaborations and resulting publications from 21 faculty investigators who represent 8 basic science and clinical departments. This roster allows IBVSTP to facilitate translation of cellular and molecular studies of inflammation-mediated disorders into preclinical studies of innovative therapies. Since its inception, a hitherto non-existent platform was formed for effective interactions of faculty preceptors and trainees within thematic "affinity groups" encompassing: (1) Innate immunity and inflammation in sepsis and pulmonary/cardiovascular infections;(2) Proinflammatory T and B lymphocyte signaling and gene expression in atherosclerosis, autoimmunity, hypertension, metabolic syndrome, and transplantation;(3) Hemopoietic cell development, trafficking, and adhesion;(4) Extracellular matrix modeling in inflammation and autoimmunity;and (5) Functional genomics, epigenetics, proteomics, structural biology, and intracellular peptide/protein delivery for proteome restoration therapy. Since its prior renewal in 2006, these conceptual and cutting edge technological resources have provided tremendous opportunities for enhanced hands-on research experience and career development to 14 predoctoral and 19 postdoctoral trainees, including those from underrepresented groups. The Program's flagship course "Functional Genomics and Proteomics: Applications to Immunobiology" provides the unifying didactic platform. The institutional course on Responsible Conduct of Research is complemented by the Program-specific discussion groups. By requesting 5 predoctoral and 5 postdoctoral trainee slots, we respond to a growing demand for training from the Academic Community. The IBVSTP Steering Committee applies stringent admission criteria for selection of training candidates, including emphasis on translational goals of proposed projects, and evaluates trainees'performance. Postdoctoral trainees with Ph.D. and/or M.D. degrees are appointed following review by the IBVSTP Steering Committee and are advised by mentoring teams that represent the Program's Affinity Groups. The input of External Advisors and Consultants and a continuing feedback from trainees provide additional training quality checkpoints that enhance the Program's strong record of preparing the next generation of investigators in fundamental, translational, and clinical research focused on inflammation as the major mechanism of diseases affecting blood and vascular systems.

Public Health Relevance

Inflammatory disorders of blood and vascular system are increasing as documented for sepsis (blood poisoning) and cardiovascular infections, atherosclerosis (narrowing of blood vessels), high blood pressure, obesity-related metabolic syndrome and diabetes. To meet the rising tide of these disorders, we need to train a new generation of scientists and physician-scientists who will master inflammation as the mechanism of these diseases and respond to them by developing new diagnostic tools, preventive measures, and therapies to reduce the growing burden of these disorders.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
2T32HL069765-11A1
Application #
8339255
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Chang, Henry
Project Start
2002-04-01
Project End
2017-08-31
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
11
Fiscal Year
2012
Total Cost
$401,853
Indirect Cost
$24,813
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Qiao, Huan; Liu, Yan; Veach, Ruth A et al. (2014) The adaptor CRADD/RAIDD controls activation of endothelial cells by proinflammatory stimuli. J Biol Chem 289:21973-83
Braun, Nicole A; Celada, Lindsay J; Herazo-Maya, Jose D et al. (2014) Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. Am J Respir Crit Care Med 190:560-71
Bonami, Rachel H; Wolfle, William T; Thomas, James W et al. (2014) NFATc2 (NFAT1) assists BCR-mediated anergy in anti-insulin B cells. Mol Immunol 62:321-8
Stouch, Ashley N; Zaynagetdinov, Rinat; Barham, Whitney J et al. (2014) I?B kinase activity drives fetal lung macrophage maturation along a non-M1/M2 paradigm. J Immunol 193:1184-93
Bonami, Rachel H; Sullivan, Allison M; Case, James B et al. (2014) Bruton's tyrosine kinase promotes persistence of mature anti-insulin B cells. J Immunol 192:1459-70
Cox, Reagan G; Erickson, John J; Hastings, Andrew K et al. (2014) Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model. J Virol 88:6368-79
DiGiandomenico, Antonio; Veach, Ruth Ann; Zienkiewicz, Jozef et al. (2014) The "genomic storm" induced by bacterial endotoxin is calmed by a nuclear transport modifier that attenuates localized and systemic inflammation. PLoS One 9:e110183
Mike, Laura A; Choby, Jacob E; Brinkman, Paul R et al. (2014) Two-component system cross-regulation integrates Bacillus anthracis response to heme and cell envelope stress. PLoS Pathog 10:e1004044
Briney, Bryan S; Willis, Jordan R; Finn, Jessica A et al. (2014) Tissue-specific expressed antibody variable gene repertoires. PLoS One 9:e100839
Richmond, Bradley W; Ploetze, Kristen; Isom, Joan et al. (2013) Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-ýý expression. J Clin Immunol 33:446-55

Showing the most recent 10 out of 70 publications